Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chugai Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥10.53T | 26.6x | 2.39 | JP¥6,395 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.2% Upside | Upgrade to Pro+ | |
| Daiichi Sankyo | Tokyo | Healthcare | Pharmaceuticals | JP¥7.31T | 25.2x | 0.79 | JP¥3,948 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.3% Upside | Upgrade to Pro+ | |
| Takeda Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥7.11T | 52.5x | -5.29 | JP¥4,555 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.6% Upside | Upgrade to Pro+ | |
| Otsuka Holdings Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥4.27T | 10.6x | 0.05 | JP¥8,084 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.5% Upside | Upgrade to Pro+ | |
| Astellas Pharma Inc. | Tokyo | Healthcare | Pharmaceuticals | JP¥3.03T | 37.1x | 0.13 | JP¥1,691 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.2% Downside | Upgrade to Pro+ | |
| Shionogi | Tokyo | Healthcare | Pharmaceuticals | JP¥2.26T | 12.6x | 0.6 | JP¥2,653.50 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5% Downside | Upgrade to Pro+ | |
| Kyowa Kirin | Tokyo | Healthcare | Pharmaceuticals | JP¥1.39T | 36.2x | -0.61 | JP¥2,653 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.8% Downside | Upgrade to Pro+ | |
| Eisai | Tokyo | Healthcare | Pharmaceuticals | JP¥1.34T | 26.7x | 0.47 | JP¥4,749 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.5% Downside | Upgrade to Pro+ | |
| Ono Pharmaceutical Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥803.08B | 18.7x | -0.29 | JP¥1,708 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.8% Downside | Upgrade to Pro+ | |
| Rohto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥580.73B | 17x | 1.26 | JP¥2,569 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.5% Upside | Upgrade to Pro+ | |
| Sumitomo Dainippon Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥554.62B | 29.5x | 0.27 | JP¥1,399 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -27.8% Downside | Upgrade to Pro+ | |
| Medipal Holdings Corp | Tokyo | Healthcare | Pharmaceuticals | JP¥554.12B | 13.7x | 2.5 | JP¥2,686.50 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.2% Downside | Upgrade to Pro+ | |
| Santen Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥529.14B | 17.4x | 0.7 | JP¥1,593.50 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32% Upside | Upgrade to Pro+ | |
| Suzuken Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥414.44B | 13.1x | 0.74 | JP¥5,859 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7% Downside | Upgrade to Pro+ | |
| Toho Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥339.18B | 16.2x | 2.53 | JP¥5,481 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.1% Downside | Upgrade to Pro+ | |
| Hisamitsu Pharmaceutical Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥305.68B | 16x | 0.41 | JP¥4,287 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.2% Upside | Upgrade to Pro+ | |
| Tsumura & Co | Tokyo | Healthcare | Pharmaceuticals | JP¥270.81B | 10.7x | 1.16 | JP¥3,626 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.1% Upside | Upgrade to Pro+ | |
| Sawai Group Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥226.4B | 16.9x | -0.45 | JP¥1,963 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.1% Upside | Upgrade to Pro+ | |
| Nippon Shinyaku | Tokyo | Healthcare | Pharmaceuticals | JP¥219.92B | 7.2x | 0.63 | JP¥3,263 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.1% Upside | Upgrade to Pro+ | |
| Kissei Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥178.17B | 15x | 1.99 | JP¥4,300 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.9% Upside | Upgrade to Pro+ | |
| Torii Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥177.7B | 32.9x | 11.22 | JP¥6,330 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -33.6% Downside | Upgrade to Pro+ | |
| Kaken Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥147.82B | 12x | 0.17 | JP¥3,903 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17% Upside | Upgrade to Pro+ | |
| Towa Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥147.68B | 9.2x | -1.7 | JP¥3,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40% Upside | Upgrade to Pro+ | |
| Mochida Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥113.26B | 18.8x | 0.5 | JP¥3,195 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Zeria Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥91.24B | 13.4x | -0.54 | JP¥2,072 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.3% Upside | Upgrade to Pro+ | |
| Kyorin Holdings Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥90.37B | 8.8x | 0.1 | JP¥1,573 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -17.4% Downside | Upgrade to Pro+ | |
| Katakura Industries | Tokyo | Healthcare | Pharmaceuticals | JP¥87.01B | 17x | 0.2 | JP¥2,755 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Nxera Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥86.33B | -26.2x | -0.39 | JP¥954 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| JCR Pharmaceuticals | Tokyo | Healthcare | Pharmaceuticals | JP¥77.38B | -14.2x | 0.06 | JP¥635 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.1% Upside | Upgrade to Pro+ | |
| ASKA Pharmaceutical Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥72.5B | 14.2x | -0.46 | JP¥2,556 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.1% Upside | Upgrade to Pro+ | |
| Vital Ksk Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥61.26B | 8.9x | 0.43 | JP¥1,274 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Cuorips | Tokyo | Healthcare | Pharmaceuticals | JP¥55.07B | -83.9x | JP¥7,050 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| Daito Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥38.32B | 20.4x | -0.5 | JP¥1,276 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.6% Downside | Upgrade to Pro+ | |
| Seikagaku Corp | Tokyo | Healthcare | Pharmaceuticals | JP¥36.29B | -40.9x | 0.29 | JP¥666 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Fuji Pharma Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥35.75B | 11.6x | -0.22 | JP¥1,470 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.6% Upside | Upgrade to Pro+ | |
| Renascience | Tokyo | Healthcare | Pharmaceuticals | JP¥33.56B | 532.7x | 4.24 | JP¥2,510 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Koa Shoji | Tokyo | Healthcare | Pharmaceuticals | JP¥32.26B | 8.9x | 0.54 | JP¥766 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Astena Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥20.59B | -10.6x | 0.06 | JP¥510 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| CanBas | Tokyo | Healthcare | Pharmaceuticals | JP¥20.07B | -17.2x | -1.76 | JP¥1,051 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| StemRIM | Tokyo | Healthcare | Pharmaceuticals | JP¥19.64B | -1.22 | JP¥322 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| Fuso Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥18.72B | 7.2x | JP¥2,190 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| Oncolys Biopharma | Tokyo | Healthcare | Pharmaceuticals | JP¥17.69B | -7.7x | -7.53 | JP¥713 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| ReproCell | Tokyo | Healthcare | Pharmaceuticals | JP¥17.33B | -136.7x | -4.12 | JP¥183 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Ohki Healthcare | Tokyo | Healthcare | Pharmaceuticals | JP¥17.07B | 6x | 0.16 | JP¥1,251 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| CellSeed | Tokyo | Healthcare | Pharmaceuticals | JP¥16.4B | -9.1x | JP¥472 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| Taiko Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥15.08B | 36.3x | 0.31 | JP¥300 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| RaQualia Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥14.09B | -24.4x | -1.11 | JP¥575 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Stella Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥13.85B | -103.5x | -1.25 | JP¥416 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Cellsource | Tokyo | Healthcare | Pharmaceuticals | JP¥13.33B | 22.8x | JP¥647 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.2% Upside | Upgrade to Pro+ | ||
| Wakamoto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥10.92B | -47.7x | JP¥314 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |